Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2025 09:51 ET | Source: Research and Markets

Bavencio (Avelumab) Markets, 2019-2024, 2024-2029F, 2034F

Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Bavencio (Avelumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
May 15, 2025 09:34 ET | Source: Research and Markets

Nivolumab Market Report 2025-2029 & 2034: Innovative Therapies Propel Success in Cancer Treatment, Strategic Collaborations Enhance Nivolumab's Efficacy in NSCLC

Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Nivolumab Market Report 2025" has been added to ResearchAndMarkets.com's offering. The nivolumab market has witnessed substantial growth, with its...
May 14, 2025 09:23 ET | Source: Research and Markets

Opdivo (nivolumab) Market Research Report 2025: Rising NSCLC Prevalence and Immunotherapy Acceptance Fueling Growth - Forecasts to 2034

Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Opdivo (nivolumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's...
May 08, 2025 04:21 ET | Source: Research and Markets

Vectibix (panitumumab) Market Research Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2034

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Vectibix (panitumumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
April 23, 2025 11:18 ET | Source: Research and Markets

Sorafenib Market and Companies Analysis Report 2025: Features Key Players - Pfizer, Bayer, AstraZeneca, Novartis, Bristol Myers Squibb & More

Dublin, April 23, 2025 (GLOBE NEWSWIRE) -- The "Sorafenib Market Report 2025" has been added to ResearchAndMarkets.com's offering.This Sorafenib market report provides a comprehensive analysis of...
April 14, 2025 04:16 ET | Source: Research and Markets

Keytruda Market to Reach $26.6 Billion by 2030 Amid Patent Expiry & Biosimilar Challenges

Dublin, April 14, 2025 (GLOBE NEWSWIRE) -- The "Keytruda Market Size, Share & Trends Analysis Report By Application (Lung Cancer, Breast Cancer, Melanoma, Hodgkin Lymphoma), By Payer...
March 27, 2025 10:26 ET | Source: Research and Markets

The Global Market for Paclitaxel Injections Presents an $11.17 Billion Revenue Opportunity by 2029 - Analysis of Key Players Pfizer, BMS, Fresenius Kabi Oncology, Abbott Labs, and Viatris Among Others

Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Paclitaxel Injection Market Report 2025"has been added to ResearchAndMarkets.com's offering.This report covers market characteristics, size and...
March 04, 2025 07:03 ET | Source: Research and Markets

Advanced Melanoma: 2025 Pipeline Insights Report Covering 55+ Companies and 60+ Pipeline Drugs, Including Vusolimogene Oderparepvec (Replimune), IO102-IO103 (IO Biotech), and BNT111 (BioNTech SE)

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Advanced Melanoma - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
February 11, 2025 10:24 ET | Source: Research and Markets

Ocular Melanoma Epidemiology Forecast Market Report 2020-2034: Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Ocular Melanoma - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.The report delivers an in-depth...
December 03, 2024 05:14 ET | Source: Research and Markets

Kaposi Sarcoma Strategic Research Report 2024: Global Market to Surpass $200 Million by 2030 as Emerging Markets Present New Opportunities

Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Kaposi Sarcoma - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Kaposi Sarcoma was...

Next Page keyboard_arrow_right